Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5)
A Contract Award Notice
by NHS SOUTH WEST - ACUTES
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1M-£20M
- Sector
- HEALTH
- Published
- 20 Aug 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
South West England: Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire
1 buyer
- NHS South West Acutes Exeter
5 suppliers
- Baxter Healthcare Thetford
- Qualasept Corsham
- Sciensus Pharma Services Burton on Trent
- Quantum Pharmaceutical Burnopfield
- Liverpool University Hospitals NHS Trust Liverpool
Description
The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags, pre-filled syringes & elastomeric devices. This procurement is being managed by the PPSA on behalf of the Royal Devon University Healthcare NHS Foundation Trust acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.
Total Quantity or Scope
Supply of various products in bags, pre-filled syringes to include Arsenic Trioxide, Avelumab, Azacitidine, Bendamustine, Bevacizumab, Blinatumomab, Brentuximab, Bupivacaine, Carfilzomib, Cetuximab, Daratumumab, Eribulin Mesylate, Etoposide, Fludarabine Fluorouracil elastomeric devices, Ifosfamide, Infliximab, Ipilimumab, Methotrexate, Natalizumab, Obinutuzumab, Paclitaxel Albumin, Panitumumab, Pemetrexed, Pertuzumab, Rituximab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Vinorelbine.
Award Detail
1 | Baxter Healthcare (Thetford)
|
2 | Qualasept (Corsham)
|
3 | Sciensus Pharma Services (Burton on Trent)
|
4 | Quantum Pharmaceutical (Burnopfield)
|
5 | Liverpool University Hospitals NHS Trust (Liverpool)
|
Award Criteria
QA Processes & Service | 90% |
Social Value | 10% |
price | 0% |
CPV Codes
- 33600000 - Pharmaceutical products
- 33690000 - Various medicinal products
- 33692100 - Infusion solutions
- 33692500 - Injectable solutions
- 33692510 - Intravenous fluids
- 33693100 - Toxins
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The following Trusts may join any Contract(s) awarded from the Tender at any time during the Contract Period including Dorset County Hospital NHS Foundation Trust, Jersey General Hospital, Princess Elizabeth Hospital, Guernsey and University Hospitals Dorset NHS Foundation Trust.
Reference
- ocds-h6vhtk-03c658
- FTS 026412-2024